Thrive Capital Management, LLC

Institutional investor · Portfolio as of Q3 2021

Top Holdings9 positions

Checking export access…
Activity:
HOOD

Robinhood Markets, Inc.

20.4M$858.9M67.5%$42.080.00%
1 qtr
New
Unranked
VMEO
VMEODelisted

VIMEO INC

5.9M$171.9M13.5%——
2 qtrssince 2021-Q2
Unchanged
0
COMP

Compass, Inc.

7.3M$96.7M7.6%$13.14+0.91%
2 qtrssince 2021-Q2
Unchanged
0
OSCR

Oscar Health, Inc.

4.8M$82.7M6.5%$17.390.00%
1 qtr
New
95
WRBY

Warby Parker Inc.

613,802$32.6M2.6%——
1 qtr
New
78
HIMS

Hims & Hers Health, Inc.

3.2M$24.1M1.9%$13.23-43.01%
3 qtrssince 2021-Q1
Decreased
0
BLND

Blend Labs, Inc.

346,970$4.7M0.4%$13.480.00%
1 qtr
New
47
TWLO

Twilio Inc.

1,741$686,0000.1%$394.16-19.06%
2 qtrssince 2021-Q2
Unchanged
0
AMPL

Amplitude, Inc.

1,362$74,0000.0%$54.340.00%
1 qtr
New
32
$1.3B
AUM
9
Positions
Q3 2021
Filing
HI rating · 2.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q3'21
New71%Increased0%Decreased10%Exited19%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg <1 quarter
<1Q56%1-4Q44%1-2Y0%2Y+0%

Thrive Capital Management, LLC manages $1.3B across 9 positions as of Q3 2021. Top holdings: HOOD (67.5%), VMEO (13.5%), COMP (7.6%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2/5.0.

Q3 2021 Summary

Added HOOD, OSCR, WRBY and 2 more; exited AFRM and Hims & Hers Health Inc; trimmed 1, led by HIMS (−12.1M shares). Top move: OSCR (NEW, conviction 95). Portfolio: $1.3B across 9 positions.

Top holdings by portfolio weight

Total AUM$1B
HOOD67.51%
VMEO13.51%
COMP7.60%
OSCR6.50%
WRBY2.56%
HIMS1.90%
BLND0.37%
TWLO0.05%
AMPL0.01%
HIMS & HERS 0.00%

Portfolio allocation by GICS sector

Sectors5
Financial Services67.51%
Unknown13.51%
Healthcare10.96%
Real Estate7.60%
Technology0.43%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Financial Services, Unknown, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(2.0 / 5.0)
Holdings P&L53
Conviction67
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used